Previous studies have shown that melittin downregulates PI3K/AKT/mTOR and MAPK signaling pathways, thereby leading to apoptosis in several tumor cells such as liver and cervical cancers and inhibits the metastatic ability of cancer cells [30,31]. The gene discussed is MTOR; the disease is cervical carcinoma.